Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT00661154
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maximize the chemotherapy delivery into the tumor for improved cancer treatment.

Key Dates

First listed
Apr 18, 2008
Start date
Feb 29, 2008
Status verified
Aug 2012
Primary completion
Jul 31, 2009
Completion
Jul 31, 2010

Study Design

Enrollment
7 participants (actual)

Primary Outcome Measure

Determine whether[18F]-5-Fluorouracil PET/CT scanning can demonstrate a difference in [18F]-5-Fluorouracil tumor uptake before and after the administration of Avastin [ Time Frame: 1-4 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305-

Find similar trials in Stanford, CA

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies